Through further in vitro and in vivo experiments at a later stage, our team will find a suitable ratio of two fatty acids or a suitable concentration of COX-2 inhibitor, in order to inhibit the invasion and metastasis of tumor cells, finally providing a new way for clinical prevention and treatment of gastric cancer. Here, PTGS2 is linked to gastric cancer.